Patient preparation for Sr-89 Chloride therapy includes which of the following?

The correct approach for patient preparation for Sr-89 Chloride therapy involves conducting a complete blood count and performing nuclear medicine bone imaging. This is essential for several reasons.

Firstly, a complete blood count helps to evaluate the patient's overall health, assessing factors such as white blood cell counts, red blood cell counts, and platelet levels. These parameters are critical for determining the patient’s eligibility for treatment and for ensuring there are no underlying hematologic conditions that could complicate therapy.

Secondly, nuclear medicine bone imaging plays a crucial role in identifying areas of bone metastasis and assessing the distribution of disease. By visualizing the skeletal system, healthcare providers can better determine the extent of bone involvement and tailor the treatment appropriately. This imaging is particularly important prior to administering Sr-89 Chloride, as the therapy is indicated primarily for pain relief in patients with metastatic bone disease.

The other choices do not adequately encompass the comprehensive preparation required prior to this specific therapy. While renal function studies may be part of overall patient assessments, they alone do not provide the necessary information about bone involvement or blood counts. Administration of antibiotics and a thorough nutritional assessment are typically irrelevant in the context of Sr-89 Chloride preparation, as the focus is more on hematologic status and the extent of bone